Clinical trial

mRNA Expression as a Biomarker of Omalizumab Response

NCT01584687

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-06-01

PhasePHASE4

Study timeline

Study start (unknown)2012-06-01Date precision: month

Registry last updated2012-04-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

OmalizumabBIOLOGICAL

Sponsors & collaborators

Instituto de Investigação em Imunologialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01584687 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.